Brief: Catalyst Pharmaceuticals Announces Settlement Of Firdapse® Patent Litigation With Lupin Pharmaceuticals
27/08/2025 24:18
Aug 26 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O: UPDATED- CATALYST PHARMACEUTICALS ANNOUNCES SETTLEMENT OF FIRDAPSE® (AMIFAMPRIDINE) PATENT LITIGATION WITH LUPIN PHARMACEUTICALS CATALYST PHARMACEUTICALS INC - LUPIN TO DELAY GENERIC FIRDAPSE LAUNCH UNTIL FEB 25, 2035 CATALYST PHARMACEUTICALS INC - AND LUPIN TO TERMINATE PATENT LITIGATION BETWEEN CATALYST/SERB AND LUPIN Source text: ID:nGNX8y5BXY Further company coverage: CPRX.O ((Reuters.Briefs@thomsonreuters.com;))